Amelia Langston

13.6k citations

177 papers · 7.5k indexed · 2 hit papers · h-index 41

Impact in

Hematology top 0.2%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Infectious Diseases top 0.5%
- Antifungal resistance and susceptibility

Papers in

Hematology 96
- Hematopoietic Stem Cell Transplantation 55
- Multiple Myeloma Research and Treatments 20
- Acute Myeloid Leukemia Research 18
Transplantation 12

Co-authors: Christopher R. Flowers Edmund K. Waller Charise Gleason Elaine A. Ostrander Thomas R. Chauncey Brenda M. Sandmaier Sagar Lonial David G. Maloney
Journals: Blood (47 papers)Biology of Blood and Marrow Transplantation (18 papers)Cancer (12 papers)Journal of Clinical Oncology (9 papers)Bone Marrow Transplantation (8 papers)
Partner nations: United States Germany South Africa

In The Last Decade

Amelia Langston

172 papers receiving 7.3k citations

Hit Papers

align trajectories log scale

Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update 2018 · 356 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2018 Journal of Clinical Oncology
2007 New England Journal of Medicine

Peers

Countries citing papers authored by Amelia Langston

Since Specialization

Citations

This map shows the geographic impact of Amelia Langston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amelia Langston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amelia Langston more than expected).

Fields of papers citing papers by Amelia Langston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amelia Langston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amelia Langston. The network helps show where Amelia Langston may publish in the future.

Co-authors

The 25 scholars most cited alongside Amelia Langston, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Amelia Langston Line = papers co-authored together Amelia Langston links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Intermediate Dose Post-Transplant Cyclophosphamide Is Associated with Faster Engraftment and Similar Other Outcomes When Compared with Full Dose Post-Transplant Cyclophosphamide Among Patients Undergoing Allogeneic Transplantation: A Single Center Retrospective Analysis Blood ·Joseph Rimando, M. Conn, William Blum, Jason T. Romancik, Colin Vale, Amelia Langston, Edmund K. Waller, Kevin Hall	2024	1
2	Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation Blood ·Leslie S. Kean, Linda J. Burns, Tzuyung D. Kou, Roxanne Kapikian, Karissa Lozenski, Amelia Langston, John Horan, Benjamin Watkins, Muna Qayed, Brandi Bratrude, Kayla Betz, Xiaoying Tang, Mei-Jie Zhang, Seán Connolly, Martin S. Polinsky, Brian Gavin, Andres Gomez‐Caminero, Marcelo C. Pasquini	2024	8
3	Abatacept for the prevention of GVHD in patients receiving mismatched unrelated transplants: a real-world analysis Blood Advances ·Sharmila Raghunandan, Lev Gorfinkel, Michael Graiser, Brandi Bratrude, Yvonne Suessmuth, Scott Gillespie, Adrianna Westbrook, Kirsten M. Williams, Michelle Long Schoettler, Leslie S. Kean, John Horan, Amelia Langston, Muna Qayed, Benjamin Watkins	2023	4
4	Evaluating Risk Factors for Clostridium difficile Infection In Stem Cell Transplant Recipients: A National Study Infection Control and Hospital Epidemiology ·Nishi Shah, William McClellan, Christopher R. Flowers, Sagar Lonial, Hannah Khoury, Edmund K. Waller, Amelia Langston, Ajay K. Nooka	2017	8
5	Managing Acute Promyelocytic Leukemia in Patients Belonging to the Jehovah’s Witness Congregation Hematology Reports ·Anand Jillella, Martha Arellano, Leonard T. Heffner, Manila Gaddh, Amelia Langston, H. Jean Khoury, Abhishek A. Mangoankar, Vamsi Kota	2017	2
6	Combination of GM-CSF With Fludarabine-Containing Regimens in Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin Lymphoma Clinical Lymphoma Myeloma & Leukemia ·Jonathon B. Cohen, Silvana Z. Bucur, Elliott F. Winton, Rajni Sinha, Leonard T. Heffner, Nassoma King, Sagar Lonial, Amelia Langston, Edmund K. Waller, Amanda Hutchison‐Rzepka, Amanda Colbert, Mary Jo Lechowicz, Christopher R. Flowers	2015	4
7	Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis Bone Marrow Transplantation ·Marcie Riches, Steven Trifilio, M Chen, Kwang Woo Ahn, Amelia Langston, Hillard M. Lazarus, D I Marks, Rodrigo Martino, Richard T. Maziarz, G A Papanicolou, John R. Wingard, Jo‐Anne H. Young, Charles L. Bennett	2015	24
8	Phase 1b Study of New Posaconazole Tablet for Prevention of Invasive Fungal Infections in High-Risk Patients with Neutropenia Antimicrobial Agents and Chemotherapy ·Rafael F. Duarte, Javier López‐Jiménez, Oliver A. Cornely, Michél Laverdière, David Helfgott, Shariq Haider, Pranatharthi Chandrasekar, Amelia Langston, John R. Perfect, Lei Ma, Marlou L. P. S. van Iersel, Nancy Connelly, Nicholas A. Kartsonis, Hetty Waskin	2014	81
9	A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation Haematologica ·Brian Kornblit, DG Maloney, Barry E. Storer, Michael B. Maris, Lars L. Vindeløv, Parameswaran Hari, Amelia Langston, Michael A. Pulsipher, Wolfgang Bethge, Thomas R. Chauncey, Thoralf Lange, Finn Bo Petersen, Kai Hübel, Ann E. Woolfrey, Mary E.D. Flowers, R Storb, Brenda M. Sandmaier	2014	28
10	Using Serum Free Light Chain (SFLC) Ratio and Serum Protein Electrophoresis (SPEP) As a Substitute For 24-Hour Urine Studies In Myeloma Patients Blood ·Ajay K. Nooka, Donald Harvey, Jonathan L. Kaufman, Amelia Langston, Dana Nickleach, Charise Gleason, Aocnp, Leonard T. Heffner, Lawrence Boise, Sagar Lonial	2013	2
11	Evaluating Risk Factors and Outcomes For Clostridium Difficile Infection (CDI) In Stem Cell Transplant (SCT) Recipients Blood ·Nishi Shah, Ajay K. Nooka, Jonathan L. Kaufman, Daniela Casbourne, Aocnp Aocnp, Donald Hutcherson, Rachael Maynard, Edmund K. Waller, Sagar Lonial, Amelia Langston	2013	1
12	A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with lymphoma Transfusion ·Jonathan L. Kaufman, Christopher R. Flowers, Karen Rados, Gary Calandra, Julie M. Vose, L. Becker Hewes, Sagar Lonial, Amelia Langston, H. Jean Khoury, Mary Jo Lechowicz, Edmund K. Waller	2012	2
13	Mobilization of Hematopoietic Progenitors from Normal Donors Using the Combination of Granulocyte-Macrophage Colony-Stimulating Factor and Granulocyte Colony-Stimulating Factor Results in Fewer Plasmacytoid Dendritic Cells in the Graft and Enhanced Donor T Cell Engraftment with Th1 Polarization: Results from a Randomized Clinical Trial Biology of Blood and Marrow Transplantation ·Sagar Lonial, Mojtaba Akhtari, Jonathan L. Kaufman, Claire Torre, Mary Jo Lechowicz, Christopher R. Flowers, Rajni Sinha, H. Jean Khoury, Amelia Langston, Edmund K. Waller	2012	13
14	Cost-Effectiveness of Posaconazole versus Fluconazole or Itraconazole in the Prevention of Invasive Fungal Infections among Neutropenic Patients in the United States Value in Health ·Amy K. O’Sullivan, Apurvakumar Pandya, George Papadopoulos, David R. Thompson, Amelia Langston, John R. Perfect, Milton C. Weinstein	2009	45
15	Five-Year Follow-Up of Patients With Advanced Chronic Lymphocytic Leukemia Treated With Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning Journal of Clinical Oncology ·Mohamed L. Sorror, Barry E. Storer, Brenda M. Sandmaier, Michael B. Maris, Judith A. Shizuru, Richard T. Maziarz, Edward Agura, Thomas R. Chauncey, Michael A. Pulsipher, Peter A. McSweeney, James C. Wade, Benedetto Bruno, Amelia Langston, Jerald P. Radich, Dietger Niederwieser, Karl G. Blume, Rainer Storb, David G. Maloney	2008	182
16	Hematopoietic cell transplantation‐comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation Cancer ·Mohamed L. Sorror, Barry E. Storer, Brenda M. Sandmaier, David G. Maloney, Thomas R. Chauncey, Amelia Langston, Richard T. Maziarz, Michael A. Pulsipher, Peter A. McSweeney, Rainer Storb	2008	199
17	Treatment of Relapsed Acute Leukemia after Allogeneic Transplantation: A Single Center Experience Biology of Blood and Marrow Transplantation ·Martha Arellano, Amelia Langston, Elliott F. Winton, Christopher R. Flowers, Edmund K. Waller	2007	76
18	Unrelated Donor Granulocyte Colony-Stimulating Factor–Mobilized Peripheral Blood Mononuclear Cell Transplantation after Nonmyeloablative Conditioning: The Effect of Postgrafting Mycophenolate Mofetil Dosing Biology of Blood and Marrow Transplantation ·Michael B. Maris, Brenda M. Sandmaier, Barry E. Storer, David G. Maloney, Judith A. Shizuru, Edward Agura, Constanze Kliem, Michael A. Pulsipher, Richard T. Maziarz, Peter A. McSweeney, James C. Wade, Amelia Langston, Thomas R. Chauncey, Benedetto Bruno, Karl G. Blume, Rainer Storb	2006	75
19	Posaconazole as Salvage Therapy for Zygomycosis Antimicrobial Agents and Chemotherapy ·Richard N. Greenberg, Kathleen M. Mullane, J.-A. H. van Burik, Issam Raad, Mark J. Abzug, Gregory M. Anstead, Raoul Herbrecht, Amelia Langston, Kieren A. Marr, Gary J. Schiller, Mindy G. Schuster, John R. Wingard, Corina Gonzalez, Sanjay G. Revankar, Gavin Corcoran, Richard J. Kryscio, R S Hare	2005	407
20	Identification of a RAPD marker linked to progressive rod-cone degeneration in dogs Mammalian Genome ·Weikuan Gu, Gregory M. Acland, Amelia Langston, Elaine A. Ostrander, Geoffrey K. Aguirre, Kunal Ray	1998	8

About Amelia Langston

Amelia Langston is a scholar working on Hematology, Transplantation, Genetics, Oncology and Infectious Diseases, having authored 177 papers that have together received 7.5k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (55 papers), Lymphoma Diagnosis and Treatment (25 papers), Antifungal resistance and susceptibility (21 papers), Multiple Myeloma Research and Treatments (20 papers), Acute Lymphoblastic Leukemia research (19 papers), Fungal Infections and Studies (19 papers), Acute Myeloid Leukemia Research (18 papers) and Chronic Lymphocytic Leukemia Research (18 papers). The work is most often cited by research in Hematology (2.3k citations), Infectious Diseases (2.4k citations), Epidemiology (2.7k citations), Oncology (2.1k citations) and Transplantation (203 citations). Amelia Langston has collaborated with scholars based in United States, Germany and South Africa. Frequent co-authors include Christopher R. Flowers, Edmund K. Waller, Charise Gleason, Elaine A. Ostrander, Thomas R. Chauncey, Brenda M. Sandmaier, Sagar Lonial, David G. Maloney, Rainer Storb and Barry E. Storer. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Cancer, Journal of Clinical Oncology and Bone Marrow Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact